Hematopoietic Growth Factors in the Treatment of Acquired Aplastic Anemia

Ronit Gurion*, Anat Gafter-Gvili, Mical Paul, Liat Vidal, Isaac Ben-Bassat, Moshe Yeshurun, Ofer Shpilberg, Pia Raanani

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


This is the protocol for a review and there is no abstract. The objectives are as follows: Evaluation of the role of HGFs combined with IST on mortality rate in patients with AA. Evaluation of the influence of HGFs on other patients' outcomes, including neutrophil recovery, hematologic response and the time to achieve it, incidence of infections, infection related mortality and the occurrence of early and late adverse events including the risk for clonal evolution such as MDS/AML.

Original languageEnglish
Article numberCD007466
JournalCochrane Database of Systematic Reviews
Issue number3
StatePublished - 12 Mar 2014


Dive into the research topics of 'Hematopoietic Growth Factors in the Treatment of Acquired Aplastic Anemia'. Together they form a unique fingerprint.

Cite this